


Strong growth across Care and Cover verticals, technological innovation, and strategic acquisitions drive PureHealth’s transformation into a global, future-ready healthcare ecosystem
PureHealth Holding, the Middle East’s largest healthcare group, announced robust financial results for the first half of 2025, with revenue reaching Dh13.6 billion—a 9 per cent year-on-year increase—and net profit hitting Dh1.03 billion, up 2 per cent from the same period last year. EBITDA rose 8 per cent to Dh2.3 billion, reflecting broad-based growth across both the healthcare and insurance segments.
The group’s strong performance was led by its Care vertical, which contributed 72 per cent of total revenue, amounting to Dh9.8 billion, a 7 per cent increase year-on-year. Growth was fueled by hospitals, diagnostics, and technology services, alongside a 13 per cent rise in outpatient volumes to 4.4 million visits and a 7 per cent increase in inpatient volumes to 108,000 visits across the UAE and UK. Expansion efforts included enhanced specialist capacity in the UAE’s SEHA and SSMC networks, and Circle Health’s successful acquisition of Fairfield Independent Hospital in the UK, increasing inpatient capacity and medical staff availability.
The Procurement segment saw a slight 5 per cent decline in revenue to Dh2.6 billion. Nonetheless, Rafed strengthened its position as the exclusive distributor for the Abu Dhabi government’s Unified Purchasing Programme, cementing its role as a central enabler within the Group’s healthcare delivery ecosystem. Meanwhile, PureLab recorded a 19 per cent increase in testing volume, totaling 16.9 million tests, boosted by contributions from SEHA and the integration of SSMC laboratories.
Technology services experienced exceptional growth, with revenue surging 170 per cent year-on-year to Dh367 million, driven by the expansion of PureCS digital infrastructure and clinical technology solutions. The Pura app exceeded 620,000 users during the period, supporting predictive analytics, digital patient engagement, and AI-enhanced care delivery.
The Cover vertical also showed significant growth, with revenue increasing 14 per cent to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums to Dh4.9 billion. Membership expanded 6 per cent year-on-year, reflecting strong customer retention and the Group’s appeal in underpenetrated markets.
PureHealth continues to optimize its operating model around two core verticals—Care and Cover—streamlining the Group’s businesses under each category. Care now encompasses hospitals, diagnostics, procurement, and technology services, while Cover includes the Group’s insurance operations.
Kamal Al Maazmi, Chairman of PureHealth, emphasized the Group’s strategic vision: “PureHealth’s strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are expanding access to care and reshaping how health is delivered, experienced, and sustained.”
Shaista Asif, Group CEO, added: “We delivered solid growth across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive coverage. We continue to enhance services through AI-powered solutions, enabling smarter, more efficient healthcare. As we expand globally, our focus remains on asset transformation, synergies, and improving health outcomes within our communities.”
The Group’s balance sheet remains strong, with a Net Debt to EBITDA ratio of 1.4x and no outstanding bank debt after repaying Dh1.85 billion ahead of its 2027 maturity. This positions PureHealth to pursue future M&A opportunities and strategic organic growth initiatives across its global healthcare platform.
With its continued focus on innovation, technology, and strategic expansion, PureHealth is not only driving financial growth but also reshaping healthcare delivery across the Middle East and beyond, creating a sustainable, patient-centric ecosystem for the future.